1 / 8

STD Diagnostics Market Analysis, Size, Share, Growth and Forecast to 2024 | Hexa Research

Global STD diagnostics market is esteemed to grow over USD 100 billion over the forecast period. Increasing awareness towards sexually transmitted diseases (STDs) along with rising government initiatives is expected to drive the market growth in this segment

Carrol
Télécharger la présentation

STD Diagnostics Market Analysis, Size, Share, Growth and Forecast to 2024 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business STD Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research "Global STD diagnostics market is esteemed to grow over USD 100 billion over the forecast period.” The global STD (sexually transmitted disease) Diagnostics Market is driven by growing awareness about STDs among the masses and greater governmental initiatives. Technological developments too play a vital role in fuelling market growth. Popularity of POC (point of care) testing propels the demand for improved products, such as diagnostic devices, kits, and reagents. A number of people have multiple sexual partners which in turn raises the possibility of contracting infections. Hence, there’s the growing need for accurate & precise diagnostics solutions. The worldwide STD diagnostics market is segmented as per types of infections, location of tests, devices, and regions. On the basis of infections, the categories are human papilloma virus (HPV), syphilis, chlamydia, vaginitis, HIV (human immunodeficiency virus), herpes simplex virus, and gonorrhea. Chlamydia, gonorrhea, and syphilis are sexually transmitted infections (STIs) caused by bacteria. Genital warts, HPV, HIV, and hepatitis genital herpes are examples of STIs caused by viruses. These microorganisms get transmitted through semen, blood, and vaginal fluids. Chlamydia is by far the most commonly occurring sexually transmitted disease. Browse Details of Report @ https://www.hexaresearch.com/research-report/std-diagnostics-market Follow Us:

  2. Your Catalyst To a Lucrative Business In terms of revenues, this segment held the highest share in the overall industry. It generated revenues surpassing USD 36 billion in 2016. However, rising cases of syphilis may contribute to more than 20% of total industry revenues over the forecast period (2016 to 2024). Based on location of tests, the market is bifurcated into laboratory testing and point of care (PoC) testing. Laboratory tests are carried out either in public health labs or in private/commercial labs. Unlike, PoC testing solutions, laboratory tests deliver more precise results. PoC tests (such as test kits) are a more convenient option because these deliver immediate results, but they are not always accurate. The introduction of bedside & mobile testing is a step towards enhanced healthcare. The industry for bedside & mobile testing may expand at a CAGR nearly 10% from 2016 to 2024. According to type of device, the worldwide STD diagnostics market is segmented into thermal cyclers - PCRs, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate reader, phone chips (microfluidics+ICT), and bench top/portable/rapid diagnostics kits. Portable/rapid diagnostics and phone chips are PoC testing devices, while the others are laboratory test devices. The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8% during the forecast period. The portable PoC testing devices industry is propelled by continuous technological innovations. It may generate revenues exceeding USD 46 billion by 2024. Geographically, the global STD diagnostics market is divided into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. Driven by surging public awareness about STIs and the presence of a well developed system of health insurance, North America dominates the global industry. Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices. As per ongoing industry trends, Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run. Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation, Abbott Laboratories, BioMerieux, Roche Holdings AG, and Becton Dickinson & Company. Recently, QuantuMDx, a U.K. based company dealing in life sciences diagnostics & tools, developed the Q- Poc. This is a highly affordable diagnostic DNA analyzer which is commonly known as the “handheld lab”. It is capable of diagnosing certain types of cancers and a number of infectious diseases (including the sexually transmitted ones). Equipped with a solar battery, the Q-Poc can analyze biological samples, for example, swabs are used to detect sexually transmitted diseases/infections. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of STD Diagnostics Market Chapter 1. Methodology and Scope 1.1. Research methodology 1.2. Research scope & assumption 1.3. List of data sources Chapter 2. Executive Summary 2.1. STD diagnostics market - Industry Summary and Key Buying Criteria, 2016 - 2024 Chapter 3. STD Diagnostics Industry Outlook 3.1. STD diagnostics market segmentation 3.2. STD diagnostics market size and growth prospects, 2016-2024 3.3. STD diagnostics market dynamics 3.3.1. Market driver analysis 3.3.2. Market restraint analysis 3.4. Key opportunities prioritized 3.5. Industry analysis - Porter's 3.6. STD diagnostics: Company market share, 2016 3.7. STD diagnostics market PESTEL analysis, 2016 Chapter 4. STD Diagnostics Types Outlook 4.1. STD diagnostics market share by type, 2016 & 2024 4.2. Chlamydia testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.3. Syphilis testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.4. Gonorrhea testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.5. Herpes Simplex Virus testing estimates and forecasts, 2016 - 2024 (USD Billion) 4.6. Human Papilloma Virus testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.7. Human Immunodeficiency Virus testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.8. Chancroid testing market estimates and forecasts, 2016 - 2024 (USD Billion) 4.9. Other devices market estimates and forecasts, 2016 - 2024 (USD Billion) Chapter 5. STD Diagnostics Location of Testing Outlook 5.1. STD diagnostics market share by location of testing, 2016 & 2024 5.2. Laboratory testing market estimates and forecasts, 2016 - 2024 (USD Billion) Follow Us:

  4. Your Catalyst To a Lucrative Business 5.2.1. Commercial/Private labs testing market estimates and forecasts, 2016 - 2024 (USD Billion) 5.2.2. Public Health Labs testing market estimates and forecasts, 2016 - 2024 (USD Billion) 5.3. Point of Care (PoC) testing market estimates and forecasts, 2016 - 2024 (USD Billion) Chapter 6. STD Diagnostics Testing Devices Outlook 6.1. STD diagnostics market share by testing device, 2016 & 2024 6.2. Laboratory devices market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.1. Thermal Cyclers - PCR market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.2. Lateral Flow Readers market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.3. Flow Cytometers market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.4. Differential Light Scattering machines market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.5. Absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA) market estimates and forecasts, 2016 - 2024 (USD Billion) 6.2.6. Others market estimates and forecasts, 2016 - 2024 (USD Billion) 6.3. Point of Care (PoC) testing market estimates and forecasts, 2016 - 2024 (USD Billion) 6.3.1. Phone chips (microfluidics + ICT) market estimates and forecasts, 2016 - 2024 (USD Billion) 6.3.2. Portable/bench top/rapid diagnostic kits market estimates and forecasts, 2016 - 2024 (USD Billion) Chapter 7. STD Diagnostics Regional Outlook 7.1. North America 7.1.1. North America market, by type, revenue (USD Billion) 7.1.1.1. U.S. market estimates and forecasts 7.1.1.2. Canada market estimates and forecasts 7.1.2. North America market, by location of testing, revenue (USD Billion) 7.1.2.1. U.S. market estimates and forecasts 7.1.2.2. Canada market estimates and forecasts 7.1.3. North America market, by testing device, revenue (USD Billion) 7.1.3.1. U.S. market estimates and forecasts 7.1.3.2. Canada market estimates and forecasts 7.2. Europe 7.2.1. Europe market, by type, revenue (USD Billion) 7.2.1.1. Sweden market estimates and forecasts 7.2.1.2. Germany market estimates and forecasts 7.2.2. Europe market, by location of testing, revenue (USD Billion) 7.2.2.1. Sweden market estimates and forecasts 7.2.2.2. Germany market estimates and forecasts Follow Us:

  5. Your Catalyst To a Lucrative Business 7.2.3. Europe market, by testing device, revenue (USD Billion) 7.2.3.1. Sweden market estimates and forecasts 7.2.3.2. Germany market estimates and forecasts 7.3. Asia Pacific 7.3.1. Asia Pacific market, by type, revenue (USD Billion) 7.3.1.1. China market estimates and forecasts 7.3.1.2. India market estimates and forecasts 7.3.2. Asia Pacific market, by location of testing, revenue (USD Billion) 7.3.2.1. China market estimates and forecasts 7.3.2.2. India market estimates and forecasts 7.3.3. Asia Pacific market, by testing device, revenue (USD Billion) 7.3.3.1. China market estimates and forecasts 7.3.3.2. India market estimates and forecasts 7.4. Latin America 7.4.1. Latin America market, by type, revenue (USD Billion) 7.4.1.1. Brazil market estimates and forecasts 7.4.1.2. Mexico market estimates and forecasts 7.4.2. Latin America market, by location of testing, revenue (USD Billion) 7.4.2.1. Brazil market estimates and forecasts 7.4.2.2. Mexico market estimates and forecasts 7.4.3. Latin America market, by testing device, revenue (USD Billion) 7.4.3.1. Brazil market estimates and forecasts 7.4.3.2. Mexico market estimates and forecasts 7.5. MEA 7.5.1. MEA market, by type, revenue (USD Billion) 7.5.1.1. South Africa market estimates and forecasts 7.5.2. MEA market, by location of testing, revenue (USD Billion) 7.5.2.1. South Africa market estimates and forecasts 7.5.3. MEA market, by testing device, revenue (USD Billion) 7.5.3.1. South Africa market estimates and forecasts Chapter 8. Competitive Landscape 8.1. Becton Dickinson and company 8.1.1. Company Overview 8.1.2. Financial Performance 8.1.3. Product Benchmarking Follow Us:

  6. Your Catalyst To a Lucrative Business 8.1.4. Strategic Initiatives 8.2. Roche Holdings AG 8.2.1. Company Overview 8.2.2. Financial Performance 8.2.3. Product Benchmarking 8.2.4. Strategic Initiatives 8.3. Hologic Inc. 8.3.1. Company Overview 8.3.2. Financial Performance 8.3.3. Product Benchmarking 8.3.4. Strategic Initiatives 8.4. BioMerieux 8.4.1. Company Overview 8.4.2. Financial Performance 8.4.3. Product Benchmarking 8.4.4. Strategic Initiatives 8.5. Alere Inc. 8.5.1. Company Overview 8.5.2. Financial Performance 8.5.3. Product Benchmarking 8.5.4. Strategic Initiatives 8.6. Danaher Corporation 8.6.1. Company Overview 8.6.2. Financial Performance 8.6.3. Product Benchmarking 8.6.4. Strategic Initiatives 8.7. Abbott Laboratories 8.7.1. Company Overview 8.7.2. Financial Performance 8.7.3. Product Benchmarking 8.7.4. Strategic Initiatives 8.8. Affymetrix 8.8.1. Company Overview 8.8.2. Financial Performance 8.8.3. Product Benchmarking 8.8.4. Strategic Initiatives Follow Us:

  7. Your Catalyst To a Lucrative Business 8.9. DiaSorin 8.9.1. Company Overview 8.9.2. Financial Performance 8.9.3. Product Benchmarking 8.9.4. Strategic Initiatives 8.10. Cepheid Inc. 8.10.1. Company Overview 8.10.2. Financial Performance 8.10.3. Product Benchmarking 8.10.4. Strategic Initiatives 8.11. Orasure 8.11.1. Company Overview 8.11.2. Financial Performance 8.11.3. Product Benchmarking 8.11.4. Strategic Initiatives Follow Us:

  8. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us:

More Related